Amgen
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
US
IE
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Amgen (AMGN) Business News
Track Amgen in real time with a live news feed covering Amgen stock news, official press releases, company announcements, and an archive of historical Amgen news. ...more
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
April Dogs Of The Dow: One To Buy
FDA Says Amgen's Tavneos Linked to Liver Injuries, Deaths
US FDA warns of liver injury cases tied to Amgen's rare disease drug
The Zacks Analyst Blog Roche Holding, AT&T and Amgen
Financial Planning Hawaii Inc. Takes Position in Amgen Inc. $AMGN
Brookstone Capital Management Purchases 3,098 Shares of Amgen Inc. $AMGN
April Dogs Of The Dow: One To Buy
FDA Says Amgen's Tavneos Linked to Liver Injuries, Deaths
US FDA warns of liver injury cases tied to Amgen's rare disease drug
The Zacks Analyst Blog Roche Holding, AT&T and Amgen
Financial Planning Hawaii Inc. Takes Position in Amgen Inc. $AMGN
Brookstone Capital Management Purchases 3,098 Shares of Amgen Inc. $AMGN
Beacon Investment Advisory Services Inc. Grows Stock Holdings in Amgen Inc. $AMGN
Chesley Taft & Associates LLC Increases Position in Amgen Inc. $AMGN
REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
Verizon (VZ) is the only Dow stock in April 2026 meeting the ideal of annual dividends from $1K invested exceeding its share price, supported by robust free cash flow. Analyst forecasts suggest the top ten Dow dividend stocks could deliver average net gains of 45.76% by April 2027, albeit with above-market volatility. Dividend dogcatcher strategy prioritizes stocks where dividends from $1K invested surpass share price; currently, only VZ qualifies, but more may reach this on market pullbacks.
Read full article
April Dogs Of The Dow: One To Buy
Seeking AlphaVerizon (VZ) is the only Dow stock in April 2026 meeting the ideal of annual dividends from $1K invested exceeding its share price, supported by robust free cash flow. Analyst forecasts suggest the top ten Dow dividend stocks could deliver average net gains of 45.76% by April 2027, albeit with above-market volatility. Dividend dogcatcher strategy prioritizes stocks where dividends from $1K invested surpass share price; currently, only VZ qualifies, but more may reach this on market pullbacks.
Read full article
FDA Says Amgen's Tavneos Linked to Liver Injuries, Deaths
WSJThe FDA said it has identified 76 cases of drug-induced liver injuries with reasonable evidence of being causally linked to Tavneos.
Read full article
US FDA warns of liver injury cases tied to Amgen's rare disease drug
ReutersThe U.S. Food and Drug Administration on Monday said it had identified cases of liver injury in patients taking Amgen's drug for a group of rare autoimmune diseases and urged healthcare providers to closely monitor patients and discontinue the treatment promptly if liver damage is suspected.
Read full article
The Zacks Analyst Blog Roche Holding, AT&T and Amgen
Zacks Investment ResearchAMGN, T, and Roche shares outperform as strong drug portfolios and wireless momentum offset key headwinds like pricing pressure and legacy declines.
Read full article
Financial Planning Hawaii Inc. Takes Position in Amgen Inc. $AMGN
Defense WorldFinancial Planning Hawaii Inc. purchased a new stake in Amgen Inc. (NASDAQ: AMGN) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 6,180 shares of the medical research company's stock, valued at approximately $2,023,000. Amgen makes up about 1.
2%
Brookstone Capital Management Purchases 3,098 Shares of Amgen Inc. $AMGN
Defense WorldBrookstone Capital Management lifted its position in Amgen Inc. (NASDAQ: AMGN) by 4.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 74,409 shares of the medical research company's stock after buying an additional 3,098 shares during the quarter. Brookstone Capital
Read full article
April Dogs Of The Dow: One To Buy
Seeking AlphaVerizon (VZ) is the only Dow stock in April 2026 meeting the ideal of annual dividends from $1K invested exceeding its share price, supported by robust free cash flow. Analyst forecasts suggest the top ten Dow dividend stocks could deliver average net gains of 45.76% by April 2027, albeit with above-market volatility. Dividend dogcatcher strategy prioritizes stocks where dividends from $1K invested surpass share price; currently, only VZ qualifies, but more may reach this on market pullbacks.
Read full article
FDA Says Amgen's Tavneos Linked to Liver Injuries, Deaths
WSJThe FDA said it has identified 76 cases of drug-induced liver injuries with reasonable evidence of being causally linked to Tavneos.
Read full article
US FDA warns of liver injury cases tied to Amgen's rare disease drug
ReutersThe U.S. Food and Drug Administration on Monday said it had identified cases of liver injury in patients taking Amgen's drug for a group of rare autoimmune diseases and urged healthcare providers to closely monitor patients and discontinue the treatment promptly if liver damage is suspected.
Read full article
The Zacks Analyst Blog Roche Holding, AT&T and Amgen
Zacks Investment ResearchAMGN, T, and Roche shares outperform as strong drug portfolios and wireless momentum offset key headwinds like pricing pressure and legacy declines.
Read full article
Financial Planning Hawaii Inc. Takes Position in Amgen Inc. $AMGN
Defense WorldFinancial Planning Hawaii Inc. purchased a new stake in Amgen Inc. (NASDAQ: AMGN) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 6,180 shares of the medical research company's stock, valued at approximately $2,023,000. Amgen makes up about 1.
2%
Brookstone Capital Management Purchases 3,098 Shares of Amgen Inc. $AMGN
Defense WorldBrookstone Capital Management lifted its position in Amgen Inc. (NASDAQ: AMGN) by 4.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 74,409 shares of the medical research company's stock after buying an additional 3,098 shares during the quarter. Brookstone Capital
Read full article
Beacon Investment Advisory Services Inc. Grows Stock Holdings in Amgen Inc. $AMGN
Defense WorldBeacon Investment Advisory Services Inc. raised its holdings in shares of Amgen Inc. (NASDAQ: AMGN) by 4.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 56,129 shares of the medical research company's stock after acquiring an additional 2,540 shares during the
Read full article
Chesley Taft & Associates LLC Increases Position in Amgen Inc. $AMGN
Defense WorldChesley Taft and Associates LLC grew its holdings in shares of Amgen Inc. (NASDAQ: AMGN) by 14.6% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 20,162 shares of the medical research company's stock after buying an additional 2,565 shares during the quarter.
Read full article
REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
PRNewsWireRepatha is the Only PCSK9 Inhibitor to Significantly Reduce the Risk of First CV Events in High-Risk Primary Prevention VESALIUS-CV Subgroup Findings Reinforce Benefit of Earlier Initiation of Repatha in High-Risk Patients, with Median 44 mg/dL LDL-C Achieved THOUSAND OAKS, Calif., March 28, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) announced today that Repatha® (evolocumab), when added to statins or other low-density lipoprotein cholesterol (LDL-C)-lowering treatments, reduced the risk of first major adverse cardiovascular (CV) events (MACE) in high-risk primary prevention patients without known significant atherosclerosis (buildup of plaque in the arteries) and with diabetes.
Read full article
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
Zacks Investment ResearchZacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read full article